Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Why would it be bad if they're being tight lipped? Also I guess that blows the wsj's article away about not being considered for OWS right???
Exactly there was last time with the wsj.... Cause uh they didn't vet it out. Next
Didn't they get it won't last time and have to put out a correction the next day????
Now the owsy and cytodyn are tied together in print. Maybe this will put a target/spot light on the OWS.
Again,
I think all countries are taking the time to go through the data, not just accepting our word. It will take a bit of time, I don't think we're out of the EUA running yet. If we were I think we'd be given phase 3, and that would be the news.
Tough call, if you need the $1800, I'd take it off the table, Gilead is down, you may be able to get in low.
Agreed, they are also on egg shells now with that plasma flop. Same can be said for other countries, they are analyzing the data.
You know Klump isn't on the board anymore right?
Would it get an eua, or full approval
Good maybe new pressures will make them look for treatments that actually have data and are effective
We just need the company to drop some significant news now. Eua from any country, uplisting, or OWS funding
What happened to this?
I do believe it is just about that time
I just tried, opened fine for me
That's where I got the quote, but was it said by Trump
Could be,
Of the possible drugs to be approved, how many of them have product ready to go? If approved today, will they be able to start administering tomorrow?
As long as Leronlimb gets approved, I don't care if he claims he invented it.
I don't mind if they take a bit longer to analyze the data, as long as they make the right decision
We have many catalysts up in the air right now. I'm hopeful that we uplist within a week or 2. I want off this OTC asap.
We have,
Pending Uplisting
Possible EUA in one or more countries
Possible OWS funding.
Anything can happen. It will be an exciting couple of weeks, I just hope we don't get up to bat and get 3 strikes!
Rumors sometimes come true!
When I go under google.com/finance
CytoDyn Inc
OTCMKTS: CYDY
Here is a list of nasdaq listings
https://www.advfn.com/nasdaq/nasdaq.asp?companies=C
Hopefully sooner than later!
Follow up article to this mornings Trump Tweet.
https://www.foxnews.com/politics/trump-fda-efforts-coronavirus-treatments
I would say yes, there are now 5 people on the BOD, 3 of which are independent.
I know that, that is how I came across him. Was he ever announced in a video or on a CC or in a PR?
Hopefully a better surprise than that last article they published about us.
Does anyone know when Brian Brothen came on board? Per his Linkedin it was July, I don't remember hearing or seeing anything.
Brian Brothen
Vice President of Global Oncology
Brian Brothen brings to CytoDyn over two decades of commercial pharmaceutical, diagnostic, and medical device oncology experience. He has excelled in sales, commercial leadership, business development, strategic planning, and key opinion leader development. Prior to joining CytoDyn, Mr. Brothen was the Vice President of Sales and Business Development for QT Ultrasound and Paradigm Dx, where he led the launch of the company’s new NGS cancer diagnostic test to help deliver personalized cancer therapy. Mr. Brothen has held numerous oncology sales and sales leadership positions at Agendia, Pharmion (Celgene), Sanofi, and Schering Plough. Mr. Brothen graduated from the University of South Florida with a degree in Business and Communications.
This is why therapeutics are needed!
Pretty crazy, but it's coming to light that it is ineffective and expensive. It would be pretty irresponsible for the FDA not to approve our drug, based on the new trials, and the 10 years of safety. I think they are going through the data with a fine toothed comb.
Considering there is no guarantee how long this would be around, I'd take it now, so we can fund and advance other trials/ hire a lobbyist, and a marketing crew.
4.5m vol in an hour and a half
$3.45 and 2m in volume in an hour...someone knows something
One day someday. We are going to get uplisting and EUA/Approval(s)
We have a runner!
Anyone have a link to Dr drew